We updated and aligned our Common Drug Review, pan-Canadian Oncology Drug Review, and Interim Plasma Protein Product Review processes.

This entry was posted on Wednesday, July 14th, 2021 at 8:34 pm and is filed under . You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.

Comments are closed.